ETON - CIK 0001710340
The table below shows Eton Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.94M | $14.94M | $21.39M | $16.30M | $14.41M | $21.30M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $11.76M | $5.36M | $3.41M | $1.85M | $5.47M | $48.00K |
| Inventory | $15.42M | $15.23M | $911.00K | $557.00K | $550.00K | $1.24M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $60.58M |
| $41.02M |
| $26.84M |
| $20.00M |
| $23.60M |
| $24.70M |
| Property, plant & equipment | $326.00K | $34.00K | $58.00K | $72.00K | $115.00K | $811.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $92.11M | $76.12M | $31.74M | $25.03M | $27.46M | $26.32M |
| Accounts payable | $10.98M | $4.17M | $1.85M | $1.77M | $1.77M | $2.34M |
| Total current liabilities | $38.49M | $19.95M | $16.24M | $6.46M | $4.56M | $3.79M |
| Long-term debt | $21.77M | $29.81M | $0.00 | $5.38M | $5.26M | $6.53M |
| Total liabilities | $65.96M | $51.70M | $16.26M | $11.95M | $9.84M | $10.66M |
| Retained earnings | -$112.49M | -$107.89M | -$104.07M | -$103.13M | -$94.11M | -$92.16M |
| Total equity | $26.15M | $24.43M | $15.48M | $13.08M | $17.63M | $15.66M |